This Post Was Syndicated Under License Via QuoteMedia
REDMOND, Wash., Sept. 19, 2019 /PRNewswire/ — Microsoft Corp. on Wednesday announced the nomination of Emma Walmsley, CEO of GlaxoSmithKline (GSK) and member of the GSK board, to the Microsoft board of directors. Walmsley will be presented for election at the company’s annual shareholders meeting, which will be held Dec. 4, 2019.
“Emma is an accomplished business leader who led major advances in research and development at GSK and will bring her significant insights and global experience to Microsoft,” said John W. Thompson, Microsoft ...
Read The Full Article On StreetSignals.com
Get the latest stock market news on StreetSignals. Follow public companies and get free stock research reports and stock market analysis data and stock tips.
All content provided by StreetSignals is subject to our Terms Of Use and Disclaimer.